Tumor immune microenvironment and nivolumab efficacy in EGFR mutation-positive non-small-cell lung cancer based on T790M status after disease progression during EGFR-TKI treatmentKoji Haratani, Kazuhiko Nakagawa, Kenya Hayashi et al.|Annals of Oncology|2017Cited by 294
Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in <i>EGFR</i> Mutation–Positive Non–Small Cell Lung CancerKohsuke Isomoto, Kazuhiko Nakagawa, Koji Haratani et al.|Clinical Cancer Research|2020Cited by 244
Mutations in the <i>SLC34A2</i> Gene are Associated with Pulmonary Alveolar MicrolithiasisHuqun, Koichi Hagiwara, Shinyu Izumi et al.|American Journal of Respiratory and Critical Care Medicine|2006Cited by 196